share_log

和黃醫藥:自願性公告-創響生物與和黃醫藥宣佈IMG-004全球Ⅰ期臨床試驗完成首例受試者給藥

HUTCHMED: VOLUNTARY ANNOUNCEMENT - Inmagene and HUTCHMED Announce First Participant in Global Phase I Trial of IMG-004

Aug 9, 2022 04:31
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more